GLI2 and cancer: In SHH-MB, GLI2 occurs in combination with amplifications of NMYC or deletion of TP53.6,10,11 MB is the most common malignant brain tumor in children, representing 60% of childhood intracranial embryonal tumors and the leading cause of pediatric cancer deaths.6